Mesirow Financial Investment Management Equity & Fixed Income Collegium Pharmaceutical, Inc Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$97.3 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$14.22 - $20.88 $4.54 Million - $6.67 Million	319,395 New	319,395 $5.66 Million
Q3 2021 Nov 04, 2021	SELL	$17.75 - $25.39 $7.39 Million - $10.6 Million	-416,244 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$21.74 - $25.28 $214,682 - $249,640	-9,875 Reduced 2.32%	416,244 $9.84 Million
Q1 2021 May 03, 2021	SELL	$19.25 - $26.1 $72,187 - $97,875	-3,750 Reduced 0.87%	426,119 $10.1 Million
Q4 2020 Feb 01, 2021	BUY	$17.83 - $22.29 $2.25 Million - $2.81 Million	126,184 Added 41.55%	429,869 $8.61 Million
Q3 2020 Nov 05, 2020	BUY	$15.78 - $20.82 $143,203 - $188,941	9,075 Added 3.08%	303,685 $6.32 Million
Q2 2020 Aug 06, 2020	SELL	$15.49 - $23.51 $73,267 - $111,202	-4,730 Reduced 1.58%	294,610 $5.16 Million
Q1 2020 Apr 28, 2020	BUY	$13.89 - $25.45 $4.16 Million - $7.62 Million	299,340 New	299,340 $4.89 Million

Others Institutions Holding COLL

# of Institutions

249

Shares Held

36.2M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$189 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$85.9 Million
1.79% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$76.5 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.14M
Shares

$69.8 Million
0.15% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.66M
Shares

$54 Million
0.1% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account